Dr. Clio A. Harper III, MD
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 49
Licensed in Texas since 1995, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: University of Oklahoma College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
TX license J8262 (first issued 1995; active) · CO license DR.0043510 (first issued 2005; active) · OR license MD18288 · WA license MD60650165 (first issued 2016; expired) -
Retina Specialist (Ophthalmology) Physician
TX license J8262 (first issued 1995; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ascension Seton Medical Center Austin Austin, TX
Medical groups
- Austin Retina Associates PLLC (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 49
- Services billed
- 208
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, aflibercept, 1 mg | 1,460 | 208 |
| Imaging of retina | 1,093 | 553 |
| Injection of drug into eye | 661 | 233 |
| Established patient complete exam of visual system | 331 | 313 |
| Established patient office or other outpatient visit, 20-29 minutes | 235 | 187 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 204 | 177 |
| Photography of the retina | 169 | 140 |
| Established patient office or other outpatient visit, 30-39 minutes | 68 | 67 |
| Established patient problem focused exam of visual system | 52 | 47 |
| New patient complete exam of visual system | 45 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prolensa (bromfenac sodium) | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 10 payments worth $444 in total to this clinician.
| Genentech, Inc. | $150 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $97.33 |
| Apellis Pharmaceuticals, Inc. | $94.00 |
| Regeneron Pharmaceuticals, Inc. | $36.98 |
| Neurotech Pharmaceuticals, Inc. | $29.57 |
| AbbVie Inc. | $21.76 |
| Genentech USA, Inc. | $14.67 |
| Food and Beverage | $444 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.